Comparison of 600 versus 300-mg clopidogrel loading dose in patients with St-segment elevation myocardial infarction undergoing primary coronary angioplasty

American Journal of Cardiology

Volumn 106, Issue 9, 2010, Pages 1208-1211

  Mangiacapra, Fabio ^a   Muller, Olivier ^a   Ntalianis, Argyrios ^a   Trana, Catalina ^a   Heyndrickx, Guy R ^a   Bartunek, Jozef ^a   Vanderheyden, Marc ^a   Wijns, William ^a   De Bruyne, Bernard ^a   Barbato, Emanuele ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; DEATH; DRUG DOSE COMPARISON; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; SURVIVAL RATE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 77958577331     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.044     Document Type: Article

References (26)

1. A.W. van 't Hof, A. Liem, H. Suryapranata, J.C. Hoorntje, M.J. de Boer, F. Zijlstra Zwolle Myocardial Infarction Study Group Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade Circulation 97 1998 2302 2306 (Pubitemid 28280383)
2. M.S. Cepeda, R. Boston, J.T. Farrar, and B.L. Strom Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders Am J Epidemiol 158 2003 280 287
3. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. Lopez-Sendon, G. Montalescot, P. Theroux, M.J. Claeys, F. Cools, K.A. Hill, A.M. Skene, C.H. McCabe, and E. Braunwald Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189 (Pubitemid 40397259)
4. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. Lopez-Sendon, G. Montalescot, P. Theroux, B.S. Lewis, S.A. Murphy, C.H. McCabe, and E. Braunwald Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA 294 2005 1224 1232
5. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of Myocardial Damage During AngioplastyPlatelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
6. R. Marcucci, A.M. Gori, R. Paniccia, B. Giusti, S. Valente, C. Giglioli, P. Buonamici, D. Antoniucci, R. Abbate, and G.F. Gensini Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
7. T. Geisler, H. Langer, M. Wydymus, K. Gohring, C. Zurn, B. Bigalke, K. Stellos, A.E. May, and M. Gawaz Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation Eur Heart J 27 2006 2420 2425
8. D.J. Fitzgerald, L. Roy, F. Catella, and G.A. FitzGerald Platelet activation in unstable coronary disease N Engl J Med 315 1986 983 989
9. G. Davi, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
10. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, C.H. McCabe, and E.M. Antman Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
11. I. Muller, M. Seyfarth, S. Rudiger, B. Wolf, G. Pogatsa-Murray, A. Schomig, and M. Gawaz Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement Heart 85 2001 92 93 (Pubitemid 32973418)
12. P.A. Gurbel, K.P. Bliden, K.A. Zaman, J.A. Yoho, K.M. Hayes, and U.S. Tantry Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study Circulation 111 2005 1153 1159
13. G. Montalescot, G. Sideris, C. Meuleman, C. Bal-dit-Sollier, N. Lellouche, P.G. Steg, M. Slama, O. Milleron, J.P. Collet, P. Henry, F. Beygui, and L. Drouet A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial J Am Coll Cardiol 48 2006 931 938
14. T. Cuisset, C. Frere, J. Quilici, P.E. Morange, L. Nait-Saidi, J. Carvajal, A. Lehmann, M. Lambert, J.L. Bonnet, and M.C. Alessi Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting J Am Coll Cardiol 48 2006 1339 1345
15. D.E. Kandzari, P.B. Berger, A. Kastrati, S.R. Steinhubl, J. Mehilli, F. Dotzer, J.M. Ten Berg, F.J. Neumann, H. Bollwein, J. Dirschinger, and A. Schomig Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization J Am Coll Cardiol 44 2004 2133 2136
16. W. Hochholzer, D. Trenk, D. Frundi, P. Blanke, B. Fischer, K. Andris, H.P. Bestehorn, H.J. Buttner, and F.J. Neumann Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention Circulation 111 2005 2560 2564
17. G. Patti, G. Colonna, V. Pasceri, L.L. Pepe, A. Montinaro, and G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) study Circulation 111 2005 2099 2106
18. M. Lotrionte, G.G. Biondi-Zoccai, P. Agostoni, A. Abbate, D.J. Angiolillo, M. Valgimigli, C. Moretti, E. Meliga, T. Cuisset, M.C. Alessi, G. Montalescot, J.P. Collet, G. Di Sciascio, R. Waksman, L. Testa, G. Sangiorgi, A. Laudito, G.P. Trevi, and I. Sheiban Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention Am J Cardiol 100 2007 1199 1206
19. J.H. Jung, P.K. Min, S.H. Lee, C.W. Sung, S. Choi, J.R. Cho, N. Lee, and K.H. Byun Clopidogrel pretreatment before primary percutaneous coronary stenting in patients with acute ST-segment elevation myocardial infarction: comparison of high loading dose (600 mg) versus low loading dose (300 mg) Coron Artery Dis 20 2009 150 154
20. G. Dangas, R. Mehran, G. Guagliumi, A. Caixeta, B. Witzenbichler, J. Aoki, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, L.E. Rabbani, H. Parise, and G.W. Stone Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 54 2009 1438 1446
21. T. Svilaas, P.J. Vlaar, I.C. van der Horst, G.F. Diercks, B.J. de Smet, A.F. van den Heuvel, R.L. Anthonio, G.A. Jessurun, E.S. Tan, A.J. Suurmeijer, and F. Zijlstra Thrombus aspiration during primary percutaneous coronary intervention N Engl J Med 358 2008 557 567
22. G.W. Stone, A.J. Lansky, S.J. Pocock, B.J. Gersh, G. Dangas, S.C. Wong, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, M. Mockel, A. Ochala, A. Kellock, H. Parise, and R. Mehran Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction N Engl J Med 360 2009 1946 1959
23. E. Di Lorenzo, R. Sauro, A. Varricchio, G. Carbone, G. Cortese, M. Capasso, T. Lanzillo, F. Manganelli, C. Mariello, F. Siano, M.R. Pagliuca, G. Stanco, G. Rosato, and G. De Luca Long-term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the Paclitaxel- or Sirolimus-Eluting Stent Versus Bare Metal Stent in Primary Angioplasty (PASEO) randomized trial Circulation 120 2009 964 972
24. F. Burzotta, M. De Vita, Y.L. Gu, T. Isshiki, T. Lefevre, A. Kaltoft, D. Dudek, G. Sardella, P.S. Orrego, D. Antoniucci, L. De Luca, G.G. Biondi-Zoccai, F. Crea, and F. Zijlstra Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials Eur Heart J 30 2009 2193 2203
25. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, and E.M. Antman Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
26. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, A. Freij, and M. Thorsen Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057